Support pediatric disease research through Kids First 2.0
Use this alert to ask your legislators to support the Gabriella Miller Kids First Research Act 2.0, which redirects penalties levied against law-breaking pharmaceutical manufacturers towards the Kids First Pediatric Research Program at the NIH. Kids First was established in 2014 and funds much-needed research on rare childhood cancers, birth defects, and other rare pediatric diseases.

Funding for the 2014 research program expires in Fiscal Year 2023. The Kids First 2.0 legislation will ensure long-term continuity of that life-saving research by providing a new source of funding - from bad actors in the drug industry, not taxpayers.

July 2021 Update: The House of Representatives passed a bill this week that provides $12.6 million for the Gabriella Miller Kids First Pediatric Research Program. Use this alert to ensure that the Senate follows suit.

    Subject
    Message Body
    Tweet
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      Home Information

      Enter Your Info